Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma. (Q33403802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

10 March 2020

main subject

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Javier Briones Meijide

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Gilles Salles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Henry Leonidas Gómez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

14

Sonia Extremera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

13

Sergio Szyldergemajn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

17

Franco Cavalli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

12

Claudia Corrado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

11

Carmen Kahatt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

Vincent Ribrag

1 reference

10 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

3

Christophe Fermé

1 reference

10 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

Dolores Caballero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Reyes Arranz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Christian Gisselbrecht

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Alessandro M Gianni

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Bernardo de Miguel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Martin Cullell-Young

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

12 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

357-363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

New drug therapies in peripheral T-cell lymphoma

10 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

21 June 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Estimates of cancer incidence and mortality in Europe in 2008.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Novel therapies for peripheral T-cell non-Hodgkin's lymphomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Effect of Aplidin in acute lymphoblastic leukaemia cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Optimal two-stage designs for phase II clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Determination of aplidin, a marine-derived anticancer drug, in human plasma, whole blood and urine by liquid chromatography with electrospray ionisation tandem mass spectrometric detection.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659946

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

31 October 2018

1 reference

12 December 2020

Peripheral T-cell lymphoma

1 reference

12 December 2020

Aplidin increases sensitivity to treatment in leukemia and lymphoma cells

1 reference

12 December 2020

Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma

1 reference

12 December 2020

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

1 reference

12 December 2020

10.3324/HAEMATOL.2012.069757

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065525%20AND%20SRC:MED&resulttype=core&format=json